These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20432307)

  • 1. An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab.
    Ferl GZ; Xu L; Friesenhahn M; Bernstein LJ; Barboriak DP; Port RE
    Magn Reson Med; 2010 May; 63(5):1366-75. PubMed ID: 20432307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
    Hsu YH; Ferl GZ; Ng CM
    Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab.
    Port RE; Bernstein LJ; Barboriak DP; Xu L; Roberts TP; van Bruggen N
    Magn Reson Med; 2010 Aug; 64(2):408-17. PubMed ID: 20665785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-aided diagnosis of breast DCE-MRI using pharmacokinetic model and 3-D morphology analysis.
    Wang TC; Huang YH; Huang CS; Chen JH; Huang GY; Chang YC; Chang RF
    Magn Reson Imaging; 2014 Apr; 32(3):197-205. PubMed ID: 24439361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix.
    Donaldson SB; West CM; Davidson SE; Carrington BM; Hutchison G; Jones AP; Sourbron SP; Buckley DL
    Magn Reson Med; 2010 Mar; 63(3):691-700. PubMed ID: 20187179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating contrast agent diffusion into the analysis of DCE-MRI data.
    Pellerin M; Yankeelov TE; Lepage M
    Magn Reson Med; 2007 Dec; 58(6):1124-34. PubMed ID: 17969007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
    Poulin E; Lebel R; Croteau E; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
    Magn Reson Med; 2013 Mar; 69(3):781-92. PubMed ID: 22570280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
    Chen W; Giger ML; Bick U; Newstead GM
    Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors.
    Kitamoto E; Chikui T; Kawano S; Ohga M; Kobayashi K; Matsuo Y; Yoshiura T; Obara M; Honda H; Yoshiura K
    Acad Radiol; 2015 Feb; 22(2):210-6. PubMed ID: 25442795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced MR imaging of carotid atherosclerotic plaque: model selection, reproducibility, and validation.
    Gaens ME; Backes WH; Rozel S; Lipperts M; Sanders SN; Jaspers K; Cleutjens JP; Sluimer JC; Heeneman S; Daemen MJ; Welten RJ; Daemen JW; Wildberger JE; Kwee RM; Kooi ME
    Radiology; 2013 Jan; 266(1):271-9. PubMed ID: 23151823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
    Jena A; Mehta SB; Taneja S
    J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.
    Pope WB; Kim HJ; Huo J; Alger J; Brown MS; Gjertson D; Sai V; Young JR; Tekchandani L; Cloughesy T; Mischel PS; Lai A; Nghiemphu P; Rahmanuddin S; Goldin J
    Radiology; 2009 Jul; 252(1):182-9. PubMed ID: 19561256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blind estimation of the arterial input function in dynamic contrast-enhanced MRI using purity maximization.
    Lin YC; Chan TH; Chi CY; Ng SH; Liu HL; Wei KC; Wai YY; Wang CC; Wang JJ
    Magn Reson Med; 2012 Nov; 68(5):1439-49. PubMed ID: 22383386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic multi-modal MR tissue classification for the assessment of response to bevacizumab in patients with glioblastoma.
    Liberman G; Louzoun Y; Aizenstein O; Blumenthal DT; Bokstein F; Palmon M; Corn BW; Ben Bashat D
    Eur J Radiol; 2013 Feb; 82(2):e87-94. PubMed ID: 23017192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
    Poulin É; Lebel R; Croteau É; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
    Magn Reson Med; 2015 Feb; 73(2):740-8. PubMed ID: 24604379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized breast lesions detection using kinetic and morphologic analysis for dynamic contrast-enhanced MRI.
    Chang YC; Huang YH; Huang CS; Chen JH; Chang RF
    Magn Reson Imaging; 2014 Jun; 32(5):514-22. PubMed ID: 24582545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of apparent diffusion coefficient and quantitative kinetic parameters for predicting additional malignancy in patients with newly diagnosed breast cancer.
    Yoo H; Shin HJ; Baek S; Cha JH; Kim H; Chae EY; Kim HH
    Magn Reson Imaging; 2014 Sep; 32(7):867-74. PubMed ID: 24907855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.